ArticleWorld journal of clinical cases2022

Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy.

Yuan-Yuan Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.